Additive manufacturing: new frontiers

The world of manufacturing is embarking upon somewhat of a transition. As it embraces new and emerging technologies, it is defining itself more than ever as a forward-thinking, disruptive sector.

Such is its evolution, the design and development of everything from pick and place robotic grippers to functional organs is now being realised through major advancements in additive manufacturing - a process by which data can be used to digitally print three dimensional (3D) objects.

Additive manufacturing is such a broad subject. In just about every sector, including across the process and chemicals industries, there is an application where additive manufacturing has some play

KW Special Projects’ Keiron Salter

Materials play a huge part in what can be achieved through additive manufacturing.

Traditionally, 3D printers use plastics, powders and resins to print prototypes, at-line machine parts and end-use components.

Mark Tyrtania, sales director at 3D printing specialist Laser Lines, says each material has its own value.

“Materials create opportunities by being able to solve unique application challenges. As new materials are developed and released into the market, the scope of applications increases,” he says.

Additive manufacturing expert Stratasys says that high-performance engineering thermoplastics - such as its own ULTEM 1010 product - are fast-becoming the most commonly used materials.

“They are robust and are applicable to a wide variety of applications,” says Jonathan Jones, a materials expert at Stratasys.

Jones says that theoretically, printing with plastics can extend the boundaries of manufacturing potential.

As the additive manufacturing sector progresses, there is an increased recognition that it can be adapted to suit the needs of multiple engineering industries, he says.

“However, I don’t think additive manufacturing will be used to compete with conventional processes. I think it will create a new element within each industry.

“Industry leaders will see the potential of additive manufacturing to make products that are more bespoke and which will add value to a company’s existing product range,” Jones says.

KW Special Projects, a company that specialises in additive manufacturing, utilises Stratasys FDM Fortus 400 3D printers to develop parts for a wide variety of industries.

“Additive manufacturing is such a broad subject,” says KW Special Projects managing director Kieron Salter.

“In just about every sector, including across the process and chemicals industries, there is an application where additive manufacturing has some play,” he says.

Though heavily regulated, the production of pharmaceuticals is a good example where addictive manufacturing could be more widely implemented, Salter suggests.

For instance, the US Food and Drug Administration broke new ground in August when it approved the manufacture of the world’s first 3D-printed drug.

Aprecia Pharmaceuticals - which manufactures the drug Spritam - will utilise a proprietary 3D printing platform to print the porous seizure medication.

However, Salter claims that pharmaceuticals firms could take the process even further.

“If you are just trying to print a batch of pills that are all the same size and shape, there is no real advantage to using additive manufacturing.

“But, if you decide to 3D print a pharmaceutical patch, as opposed to a batch of pills, you can make that patch bespoke and specific to an individual’s pharmaceutical requirements. That’s where a major advantage of additive manufacturing will come from,” he says. 

Having the ability to 3D print pharmaceuticals, among other products, has raised a number of regulatory concerns, however.

Salter argues that some concerns are more valid than others.

“Just because you could potentially 3D print a drug, does not mean you will have access to the chemicals or the information required to print those pills.”

Salter says the idea that 3D printing will empower people to attempt highly dangerous manufacturing practices is mostly unfounded.

“Producing drugs and other heavily regulated products via 3D printing would still only ever happen in factories and under very strict controls.”

While 3D-printed pharmaceuticals are in the very early stages of development, 3D-printed automation is a more mature sector.

Automata Technologies is a UK-based robotic automation company co-founded by former architects Mostafa ElSayed and Suryansh Chandra.

They have only been in business for less than a year, but Automata Technologies has already developed a functional, 3D-printed plug-and-play robotic arm known as ‘EVA’.

“The prototypes we have are almost completely 3D-printed,” says Chandra.

“Even the gearing is 3D-printed. Nearly all the complex mechanisms within EVA are 3D-printed. It’s only the belts, screws and electronic components that aren’t.”

Chandra says that without the option to 3D-print EVA, the gearing would have been particularly difficult to create.

“In the UK, if an engineer designed the gearing it would have had to go through several iterations before it could ever be properly tested,” Chandra says.

“Essentially, you would have to make the mould, cast it and then test to see if it worked. It would cost thousands of pounds more than simply 3D printing the part.”

Chandra says that Automata Technologies is almost at a point where it can begin servicing the manufacturing sector.

“The first people to uptake the robot would receive a 3D version for trials, which we expect will take until about April next year,” he says.

Ultimately, Chandra wants to automate many of the 93% of tasks in manufacturing that are currently done by hand, but which he says could be better conducted by a robot.

“We are more than happy to take the approach of discovering how many different industries want and need a tool like EVA,” Chandra says.